The chemical class known as CLEC-5A activators comprises a group of diverse compounds that can stimulate or modulate the expression and activity of the C-type lectin receptor CLEC-5A within various biological contexts. CLEC-5A, a type II transmembrane receptor predominantly expressed on myeloid cells such as macrophages and neutrophils, plays a crucial role in the innate immune system by recognizing and binding to pathogens, particularly viruses and bacteria. Activation of CLEC-5A initiates downstream signaling events that trigger immune responses, including proinflammatory cytokine production and the release of antimicrobial factors. Within this chemical class, one prominent group of activators includes synthetic double-stranded RNA analogs like Poly(I:C) and Poly(I:C) (High Molecular Weight). These molecules mimic viral infections and can activate pattern recognition receptors (PRRs) on immune cells, particularly toll-like receptors (TLRs), which can subsequently signal through pathways involving CLEC-5A. Activation of CLEC-5A by Poly(I:C) and similar compounds can trigger immune responses, potentially contributing to host defense mechanisms against viral infections.
Additionally, various other chemical activators within this class, such as Lipopolysaccharide (LPS) and Tumor Necrosis Factor-alpha (TNF-α) act as immune stimulants that indirectly influence CLEC-5A. For instance, LPS, a component of the cell wall of Gram-negative bacteria, activates immune cells, leading to immune responses that may include CLEC-5A activation. TNF-α, a proinflammatory cytokine, can indirectly affect CLEC-5A expression by modulating the immune microenvironment.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Synthetic double-stranded RNA analog that mimics viral infections, potentially upregulating CLEC-5A as part of antiviral defense mechanisms. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
Component of the cell wall of Gram-negative bacteria that activates immune cells, indirectly influencing CLEC-5A expression within the immune cascade. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Protein kinase C (PKC) activator that triggers signaling pathways in immune cells, potentially influencing CLEC-5A expression through PKC-mediated pathways. | ||||||
Lipoteichoic acid | 56411-57-5 | sc-507479 | 5 mg | $248.00 | ||
Component of the cell wall of Gram-positive bacteria that activates immune cells and initiates immune responses, potentially impacting CLEC-5A expression within the immune defense. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
Synthetic imidazoquinoline compound that activates Toll-like receptor 7 (TLR7) and promotes immune responses, potentially influencing CLEC-5A expression indirectly. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Immune response modifier that activates TLR7, inducing immune responses that may impact CLEC-5A expression as part of immune activation. | ||||||